Skip to main content
evidena care

Access & prescription

Cannabis follow-up prescription in Switzerland: validity and checks

A narcotics prescription is valid for one month and covers at most three months of treatment. How a follow-up prescription comes about and the role of check-ups.

Key points

  • Under Art. 47 BetmKV, a narcotics prescription is valid for one month. As a rule, the quantity covers one month, and if circumstances justify it, at most three months of treatment.
  • A follow-up prescription is a new medical prescription. Whether it is issued is decided by the doctor after a follow-up check.
  • The follow-up consultation covers effects, side effects, concomitant medication and everyday life, such as fitness to drive.
  • The doctor reports the course of treatment to the FOPH after one and after two years of treatment.
  • Plan the follow-up consultation in good time so that there is no gap. Do not change how you take the medicine yourself.

In Switzerland, a cannabis follow-up prescription is a new medical prescription, not an automatic renewal. The Narcotics Control Ordinance sets two limits: a narcotics prescription is valid for one month, and the quantity prescribed may cover at most the requirement for three months of treatment.1

Before a follow-up prescription, the doctor therefore assesses the course of treatment: how is the therapy working, which side effects have occurred, has anything changed in your other medication? Whether the treatment continues, is adjusted or is ended is decided by the doctor on their own responsibility.3

What the BetmKV requires for follow-up prescriptions

Cannabis medicines containing THC are prescribed on the official narcotics prescription. Article 47 of the Narcotics Control Ordinance (BetmKV) applies to this prescription:1,2

  • Validity: the prescription is valid for one month.
  • Quantity: the quantity prescribed may not exceed the requirement for one month. If circumstances justify it, it may cover at most three months. In that case, the exact duration of treatment must be stated on the prescription.
  • Content: among other things, the prescription states the medicine, dosage form, dosage, quantity and instructions for use.
  • Documentation: the doctor signs the prescription and keeps a copy in your medical record.

In addition, Article 46 applies: only someone who has examined you personally may prescribe.1 These rules apply to the first prescription just as they do to every follow-up prescription.

1 month

validity of a narcotics prescription; the quantity covers at most 3 months of treatmentSource: BetmKV Art. 47

Validity and treatment duration: two different periods

The two periods are often confused. The one-month validity concerns filling the prescription: within this period you must present it at the pharmacy. The treatment duration of up to three months concerns the quantity: this is how long the medicine lasts if you use it as prescribed.1

For planning, this means: the follow-up prescription is due towards the end of the treatment duration, not after one month. Bear in mind, however, that from the date of issue another month runs for filling it. What to do if a prescription is lost is explained in the article Lost cannabis prescription.

Why a check-up is needed before the follow-up prescription

Since 2022, responsibility for the treatment has rested exclusively with the doctor.3 This includes regularly checking whether benefits and risks are still in proportion.

The evidence shows why this is important. In a meta-analysis on chronic pain, non-inhaled cannabis medicines led to a small to very small improvement in pain, function and sleep compared with placebo. Dizziness occurred considerably more often in studies with at least three months of follow-up than in shorter studies.4 For chronic pain, the BMJ guideline weakly recommends a treatment trial, as an add-on to standard treatment.5 A trial means: only the course of treatment shows whether it is worthwhile.

What is discussed in the follow-up consultation

The follow-up consultation is a progress check. Typical topics are:

  • Effect: have the complaints changed, for example pain, sleep or everyday functioning? A symptom diary can help.
  • Side effects: dizziness, tiredness, concentration problems, mood changes or palpitations. More on this in Cannabis side effects.
  • Concomitant medication: new or changed medicines can cause interactions.
  • Everyday life: work, driving, travel. What applies to driving is described in Driving with a prescription.
  • Use: whether use is working as prescribed and whether an adjustment is needed is decided by the doctor.

Do not change the dose or how you take the medicine yourself, only in consultation with your doctor. This also applies to your other medicines: with benzodiazepines, antidepressants, opioids or blood pressure medicines, stopping abruptly can be dangerous, so only do so with medical supervision.

Reporting to the FOPH and cost approval

The prescribing doctor reports cannabis treatments to the FOPH. The first prescription is recorded, and follow-up reports are required after one and two years of treatment or if treatment ends earlier. Among other things, the preparation, dosage, concomitant medication, effects and side effects are reported. The data are stored in coded form.2

If you have cost approval from your health insurer, check the period for which it applies. Reimbursement of medicines in individual cases is governed by Articles 71a to 71d of the Health Insurance Ordinance (KVV) and requires cost approval.2,6 Clarify with your doctor in good time whether a new request is needed to continue. More on this in the section Costs.

Planning the follow-up prescription in good time

To avoid a gap, simple planning is useful:

  1. Note the date: write down when the prescription was issued and for which treatment duration it applies.
  2. Book early: arrange the follow-up consultation a few weeks before the end of the treatment duration.
  3. Collect observations: note effects, side effects and new medicines.
  4. Inform the pharmacy: ask whether your pharmacy has the medicine in stock or needs to order it.

If the medicine runs out earlier than planned, tell the practice. A follow-up prescription remains a medical decision.1

When the therapy is adjusted or ended

Not every progress check ends with an unchanged follow-up prescription. The doctor may adjust the prescription, for example the dosage form or quantity, or end the treatment. Reasons may be insufficient effect, troublesome side effects or new contraindications, for example a pregnancy or a new mental illness. In the studies in the meta-analysis by Wang and colleagues, dizziness, drowsiness, nausea and transient cognitive impairment, among others, occurred more often with cannabis medicines.4

The end of treatment is also reported to the FOPH if it occurs before the end of the first or second year of treatment.2 How ending treatment works in practice is something the doctor discusses with you. It is best to return leftover narcotics to the pharmacy rather than dispose of them in household waste. Ask there.

Follow-up prescription for holidays, travel and moving house

If you will be away for a longer period, raise this early in the follow-up consultation. The quantity on one prescription is limited to at most three months of treatment; the BetmKV does not provide for a longer stock prescription.1 For travel to Schengen states you also need a certificate; more on this in the article Schengen certificate for narcotics.

If you move within Switzerland, your previous doctor remains responsible until you hand over the treatment. If you change practice, the new doctor must examine you personally before issuing a prescription.1 Bring reports and the previous prescription details with you.

How it works at evidena

At evidena, check-up appointments take place by video. Over the course of treatment, the doctor discusses your experience and adjusts your care if necessary. Whether a follow-up prescription is issued is decided by the doctor. A prescription must be filled within one month. As a rule, the prescribed quantity covers one month, in justified cases at most three months of treatment.1

Prices for follow-up consultations are on the page Costs. You can book an appointment at https://portal.evidena.care/appointments. We answer questions via WhatsApp or at info@evidena.care.

Conclusion

A cannabis follow-up prescription is a new prescription after a progress check. The prescription is valid for one month, and the quantity covers at most three months of treatment. Plan the follow-up consultation in good time and change how you take the medicine only in consultation with your doctor.

Frequently asked questions

How long is a cannabis prescription valid?

A narcotics prescription is valid for one month. You must fill it at a pharmacy within this period, even if the prescribed quantity covers up to three months of treatment.

How much may be on one prescription?

In principle, the requirement for one month. If circumstances justify it, the doctor may prescribe for up to three months and must state the treatment duration on the prescription.

Do I need an appointment for every follow-up prescription?

As a rule, yes: the follow-up prescription requires a medical assessment of the course of treatment. How often check-ups are necessary is determined by your doctor.

Will I get the follow-up prescription automatically?

No. Every follow-up prescription is a new medical decision. The doctor may continue, adjust or end the therapy.

What if my medicine runs out before I have an appointment?

Contact your practice early. Do not change how you take it yourself, only in consultation with your doctor.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 46 und 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)
  2. FAQ Cannabisarzneimittel, Bundesamt für Gesundheit BAG, 4. März 2025 (accessed 13 November 2026)
  3. Gesetzesänderung Cannabisarzneimittel, Bundesamt für Gesundheit BAG (accessed 13 November 2026)
  4. Wang L et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021;374:n1034. doi:10.1136/bmj.n1034
  5. Busse JW et al. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. BMJ. 2021;374:n2040. doi:10.1136/bmj.n2040
  6. Verordnung über die Krankenversicherung (KVV), SR 832.102, Art. 71a bis 71d, Fedlex (accessed 13 November 2026)

Written by evidena.care editorial team · Published 13 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.